Replicel

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sausage
    Senior Member
    • Jan 2012
    • 1063

    They are currently in Phase 2a, does this mean there is a Phase 2b next? how many letters of the alphabet do they go through before getting to Phase 3?

    Comment

    • Mojo Risin
      Senior Member
      • Mar 2011
      • 157

      Originally posted by sausage
      They are currently in Phase 2a, does this mean there is a Phase 2b next? how many letters of the alphabet do they go through before getting to Phase 3?
      LOL.

      I think Phase 3 is a myth.

      Comment

      • clandestine
        Senior Member
        • Aug 2011
        • 2002

        Originally posted by Mojo Risin
        LOL.

        I think Phase 3 is a myth.
        LOL.

        Go away.

        Comment

        • Jamie
          Junior Member
          • Sep 2011
          • 10

          So are we more excited about Replicel or Histogen?

          Comment

          • hairysituation
            Senior Member
            • Feb 2012
            • 206

            Originally posted by Jamie
            So are we more excited about Replicel or Histogen?
            The majority are most excited about Replicel, because their treatment is more ideal. It will potenitally regrow DHT-resistant follicles. That means no more balding. But it may not be as helpful to people with NW7, as for people with NW2-3, because a stopper for a balding progression isn't very excited news for a man with no hair.

            Comment

            • gmonasco
              Inactive
              • Apr 2010
              • 865

              Originally posted by sausage
              They are currently in Phase 2a, does this mean there is a Phase 2b next? how many letters of the alphabet do they go through before getting to Phase 3?
              It's not uncommon for Phase 2 clinical trials to be divided into Phase 2a and Phase 2b, but I can't recall ever having seen a Phase 2c trial.

              Comment

              • gmonasco
                Inactive
                • Apr 2010
                • 865

                Originally posted by lpenergy
                According to Replicel's interviews, they are able to stimulate dormant follicles-turn them back "on" to growing plus they are able to grow brand new follicles.
                In an interview a couple of months ago, David Hall (CEO of Replicel) said:

                The second key interim object is an indication of efficacy at 6 months or specifically, the increase in density of existing hair and indication of new hair follicles.
                I'm a little puzzled: If Replicel's treatment resulted in an increased hair count, how would they be able to distinguish between regrowth of existing hairs and the creation of new hairs?

                Comment

                • hairysituation
                  Senior Member
                  • Feb 2012
                  • 206

                  I think you can bet on stocks dropping in value and then make a profit of it. If you bet on Replicel's trial results beiing unsuccesful, and ergo considering that the stocks will drop in value, you can make a profit of it. That way you will either make money or have a great hope for the future regarding hairloss. It will be kind of a win-win situation!

                  Comment

                  • lpenergy
                    Member
                    • Mar 2012
                    • 60

                    Originally posted by gmonasco
                    In an interview a couple of months ago, David Hall (CEO of Replicel) said:



                    I'm a little puzzled: If Replicel's treatment resulted in an increased hair count, how would they be able to distinguish between regrowth of existing hairs and the creation of new hairs?
                    I think that is the question the Spencer should ask in the next interview. In the mice tests, they marked the injected cells with fluoresence I believe so that they were able to distinguish between brand new follicles which all had flourescent markers compared with pre-existing follicles that maybe only had a couple of new dsc cells that were recruited into existing follicles. I guess that is a question whether injected cells were marked in some way? It seems that may not be safe.

                    Comment

                    • Pate
                      Senior Member
                      • Sep 2011
                      • 417

                      Originally posted by hairysituation
                      Can you please show where you got the information from about the price? All Replicel has said about the price is that it would be compatable and then some, compared to the hair transplant prices. And why would you have to go there every second year? Can you please explain your reasoning?
                      The 15k figure came from the stockbroker's report on Replicel that was posted a few pages back. It was the proposed revenue figure for Replicel, which would mean the cost of the procedure would be significantly more expensive because the doctor or clinic that administers it needs to take their cut too.

                      But I think it was just a plucked-out-of-the-air figure, not based on anything official from Replicel. To be honest the whole valuation thing in that report was pretty lame but broker clients want to see hard numbers, not just potential, so they had to come up with a valuation metric.

                      The reason for having to go back is because it's likely it will take multiple treatments to achieve full density. Even if they achieve a 100% increase in hair count (which is more than they are looking for), if you have 10% terminal hairs left then you will only have 20% of your original terminal hair density after the procedure.

                      There's no reason for it to be two years though. Six weeks to three months is the sort of timeframe they are talking about for repeat treatments of Histogen.

                      Comment

                      • Kiwi
                        Senior Member
                        • Mar 2011
                        • 1087

                        Originally posted by Pate
                        The 15k figure came from the stockbroker's report on Replicel that was posted a few pages back. It was the proposed revenue figure for Replicel, which would mean the cost of the procedure would be significantly more expensive because the doctor or clinic that administers it needs to take their cut too.

                        But I think it was just a plucked-out-of-the-air figure, not based on anything official from Replicel. To be honest the whole valuation thing in that report was pretty lame but broker clients want to see hard numbers, not just potential, so they had to come up with a valuation metric.

                        The reason for having to go back is because it's likely it will take multiple treatments to achieve full density. Even if they achieve a 100% increase in hair count (which is more than they are looking for), if you have 10% terminal hairs left then you will only have 20% of your original terminal hair density after the procedure.

                        There's no reason for it to be two years though. Six weeks to three months is the sort of timeframe they are talking about for repeat treatments of Histogen.
                        Speaking of Histogen.... WTF! Where are they?!?

                        Comment

                        • Pate
                          Senior Member
                          • Sep 2011
                          • 417

                          Originally posted by lpenergy
                          I think that is the question the Spencer should ask in the next interview. In the mice tests, they marked the injected cells with fluoresence I believe so that they were able to distinguish between brand new follicles which all had flourescent markers compared with pre-existing follicles that maybe only had a couple of new dsc cells that were recruited into existing follicles. I guess that is a question whether injected cells were marked in some way? It seems that may not be safe.
                          I think they were genetically engineered cells carrying firefly-type genes to make them fluoresce. That won't be happening with the human trials, I imagine.

                          So I agree, this would be a good question to put to Replicel.

                          Comment

                          • Pate
                            Senior Member
                            • Sep 2011
                            • 417

                            Originally posted by Kiwi
                            Speaking of Histogen.... WTF! Where are they?!?
                            Didn't they start their next trial around January? The eight injections followed by another eight at six weeks.

                            So we might get a three-month update from them pretty soon too.

                            Comment

                            • hairysituation
                              Senior Member
                              • Feb 2012
                              • 206

                              I actually believe more in Histogen than Replicel, at least temporary. They have actually showed real results with their trials. So for a guy like me with a NW2, I guess I can archive a great result with this kind of results:

                              Comment

                              • clandestine
                                Senior Member
                                • Aug 2011
                                • 2002

                                Didn't Histogen achieve something like 70% regrowth at 12 month mark?

                                EDIT: Nevermind, poster above me just linked to a picture that shows this. Doesn't look terribly significant to me for some reason, though (based on those two photos).

                                Comment

                                Working...